EUTM file information

018633849

COSMX


January 6, 2022

Trademark Summary

The trademark application COSMX was filed by Bruker Spatial Biology, Inc., a U.S. corporation (the "Applicant"). The application was published for oppositions on June 27, 2022, and it was registered by office on October 4, 2022 without any oppositions.

The application was filed in Danish (English was selected as the second language).

Appointment and Replacement of representative of the trademark registration was recorded on April 3, 2024. A transfer of the trademark registration was recorded on September 18, 2024.


Goods And Services

  • The mark was filed in class 1 with following description of goods:
    1. Reagents for scientific, research or non-medical use in the fields of pathology, immunohistochemistry, in situ-hybridization, proteomics, RNA transcription, RNA translation, gene expression profiling and nucleic acid sequencing
    2. Diagnostic reagents for scientific or research use in the fields of cancer, neurology and infectious disease
    3. Reagents for scientific, research or non-medical or veterinary diagnostic use relating to molecular identification and digital quantification
    4. Reagents for scientific, research or non-medical or veterinary diagnostic use containing antibodies and nucleic acids
    5. Reagent kits comprising primarily reagents for scientific, research or non-medical or veterinary diagnostic use in the fields of cancer, neurology and infectious disease
    6. Reagents for immuno-histochemistry detection and in situ-hybridization detection for scientific, research or non-medical or veterinary diagnostic use
    7. Test kits for scientific, research or non-medical or veterinary diagnostic use comprising reagents, slides, solid matrix materials, microfluidic devices and support documentation, namely, instructional manuals, therefor
    8. Test kits comprising reagents for scientific, research or non-medical or veterinary diagnostic use relating to molecular identification and digital quantification
    9. Reagents for in vitro use in clinical chemistry and molecular biology
    10. Multiparameter quantitative detection and analysis products and technology, for research and diagnostics for a variety of uses in the health care and other life science sectors, namely, reagents for scientific or medical research use, diagnostic preparations and reagents for scientific or research uses, namely, pathology, immunohistochemistry, in situ-hybridization, proteomics, RNA transcription, RNA translation, gene expression profiling and nucleic acid sequencing
    11. Test kits, consisting of chemical preparations for scientific purposes, in particular for the detection, diagnosis, progress monitoring and progress pre-diction of diseases, including inflammations, infections, disorders of the central nervous systems, cardiovascular, neurological, endocrine, autoimmune and genetic disorders and cancers.
  • The mark was filed in class 5 with following description of goods:
    1. Diagnostic reagents for medical or veterinary use in the fields of pathology, immunohistochemistry, in situ-hybridization, proteomics, RNA transcription, RNA translation, gene expression profiling and nucleic acid sequencing
    2. Diagnostic reagents for medical or veterinary use in the fields of cancer, neurology and infectious disease
    3. Diagnostic reagent kits comprising primarily of diagnostic reagents for medical or veterinary use in the fields of cancer, neurology and infectious disease
    4. Chemical reagents for medical use
    5. Reagents for medical or veterinary use containing antibodies and nucleic acids
    6. Diagnostic test kits for medical use comprising primarily reagents, slides, solid matrix materials, microfluidic devices sold as a unit with instructional manuals therefor
    7. Medical or veterinary diagnostic kits comprising medical or veterinary diagnostic reagents for use in detecting the presence of analytes in samples and identifying sample type, and equipment, namely, medical diagnostic immuno-assays for screening samples detecting the presence of analytes in samples and identifying sample type, sold as a unit with instructional manuals
    8. Diagnostic preparations in the nature of antibodies, for medical and veterinary purposes
    9. Reagents and diagnostic reagents for medical or veterinary purposes
    10. Diagnostic preparations in the nature of in situ hybridization probes, for medical and veterinary purposes
    11. Medical or veterinary diagnostic reagents for pathology, immunohistochemistry, in situ-hybridization, proteomics, RNA transcription, RNA translation, gene expression pro-filing and nucleic acid sequencing
    12. Medical diagnostic re-agents and assays for testing of body fluids or tissue
    13. Kits consisting primarily of medical or veterinary diagnostic reagents and assays for testing of body fluids or tissue
    14. Reagents in the form of cell markers and molecule markers including antibodies and nucleic acids for medical or veterinary purposes
    15. Medical diagnostic reagents for use in the fields of pathology, immunohistochemistry, in situ-hybridization, proteomics, RNA transcription, RNA translation, gene expression profiling and nucleic acid sequencing
    16. Medical diagnostic reagents for use relating to molecular identification and digital quantification
    17. Medical diagnostic reagents containing antibodies and nucleic acids
    18. Medical diagnostic reagents for use in the fields of cancer, neurology and infectious disease
    19. Medical diagnostic reagents for immuno-histochemistry detection and in situ-hybridization detection
    20. Reagents for veterinary diagnostic use in the fields of pathology, immunohistochemistry, in situ-hybridization, proteomics, RNA transcription, RNA translation, gene expression profiling and nucleic acid sequencing
    21. Reagents for clinical or medical laboratory use, namely, reagents for pathology, immunohistochemistry, in situ-hybridization, proteomics, RNA transcription, RNA translation, gene expression profiling, nucleic acid sequencing, and clinical, oncology, neurology, and infectious disease diagnostics.
  • The mark was filed in class 9 with following description of goods:
    1. Automated apparatus in the nature of automated laboratory equipment and computer systems comprised of computer hardware and software for detection and analysis of biomolecules for scientific use
    2. Automated apparatus in the nature of automated laboratory equipment and computer systems comprised of computer hardware and software for scientific research, namely, for detecting, collecting and processing optical signals and images, into data for use in the analysis of biomolecules in connection with scientific or medical research
    3. Automated apparatus in the nature of automated laboratory equipment in the nature of digital imagers, digital displays, microscopes, robotics, fluidic stations and computer systems for staining and/or visualization of tissue or cell based samples for diagnostic or scientific use
    4. Automated apparatus in the nature of automated laboratory equipment in the nature of digital imagers, digital displays, microscopes, robotics and computer systems for digitizing images of biological tissue for use in connection with pathology
    5. Automated apparatus in the nature of automated laboratory equipment in the nature of digital imagers, digital displays, microscopes, robotics and computer systems for capturing digital images of microscope slides of biological tissue, storage of digitized microscope slide images in a data storage area, and display of digitized microscope slide images
    6. Automated apparatus in the nature of automated laboratory equipment in the nature of digital imagers, digital displays, microscopes, robotics, fluidic stations and computer systems comprised of computer hardware and software for detection and analysis of, pathology, gene expression, RNA transcription, RNA translation and nucleic acid sequencing
    7. Computer hardware and software to enable pathologists to diagnose disease
    8. Computer hardware and software for the electronic scanning of clinical pathology slides
    9. Computer hardware and software for pathologists to render and report diagnoses and results of scientific research
    10. Computer hardware and software for scientific or research uses, namely, pathology, immunohistochemistry, in situ-hybridization, proteomics, RNA transcription and microRNA expression profiling and nucleic acid sequencing
    11. Computer hardware and software for digitizing, processing and storing images of biological tissues and cells
    12. Computer hardware and software for analyzing the results of tissues and cell based samples obtained through operation of tissue and cell sample staining and visualization apparatus
    13. Computer hardware and software for identifying and diagnosing cancer and other diseases and processing digital images
    14. Computer hardware and software for viewing, analyzing, managing, reporting, and archiving digital images
    15. Laboratory equipment for sample preparation, mixing, hybridization, incubation, washing, location and imaging, namely, robotic equipment, fluid mixers, pumps, valves, and containers, reagent holders, sample containers and microfluidic devices, optical devices, scanning microscopes, fluorescent microscopes, digital micromirror devices, electromagnetic sensors and replacement parts therefor in the fields of scientific research
    16. Computer systems, namely, software and data files to acquire, analyze, manage and report biological information
    17. Instruments for scientific, research or non-medical use in the fields of pathology, immuno-histochemistry, in situ-hybridization, proteomics, RNA transcription, RNA translation, gene expression profiling and nucleic acid sequencing
    18. Multiparameter quantitative detection and analysis products and technology, namely computer hardware, computer software, digital imagers, digital displays, microscopes, robotics, fluidic stations and computer systems, integral circuits, data transmission and data processing apparatus, computer terminals, computer peripherals, observation instruments, optical devices, scanning microscopes, fluorescent microscopes, digital micromirror devices, electromagnetic sensors and replacement parts therefor, all for diagnostics for a variety of uses in health care, namely, pathology, immunohistochemistry, in situ-hybridization, proteomics, RNA transcription, RNA translation, gene expression profiling and nucleic acid sequencing.
  • The mark was filed in class 10 with following description of goods:
    1. Clinical and medical diagnostic instruments, namely, spatial molecular imagers
    2. Clinical and medical diagnostic instruments, namely, histopathology instruments and nucleic acid sequencers
    3. Clinical and medical diagnostic instruments for analysis of tissue and/or cell based samples, all for medical purposes
    4. Clinical and medical diagnostic instruments for performing immunohistochemistry and in situ-hybridization staining reactions, histological and pathological staining and image processing and analysis
    5. Histopathology instruments for clinical purposes
    6. Clinical and medical diagnostic instruments for immunohistochemistry and in situ-hybridization analyses
    7. Clinical and medical diagnostic instruments for the electronic scanning of clinical pathology slides, processing and storing images of biological tissues and cells and digitizing, processing and storing images of biological tissues and cells
    8. Instruments for veterinary diagnostic use in the fields of pathology, immunohistochemistry, in situ-hybridization, proteomics, RNA transcription, RNA translation, gene expression profiling and nucleic acid sequencing
    9. Diagnostic instruments for medical or veterinary use in the fields of pathology, immunohistochemistry, in situ-hybridization, proteomics, RNA transcription, RNA translation, gene expression profiling and nucleic acid sequencing
    10. Multiparameter quantitative detection and analysis products and technology, namely apparatus and instruments for diagnostics for a variety of uses in health care, namely, pathology, immunohistochemistry, in situ-hybridization, proteomics, RNA transcription, RNA translation, gene expression profiling and nucleic acid sequencing.
  • The mark was filed in class 42 with following description of goods:
    1. Research and product development services for others in the field of biotechnology
    2. Medical and scientific research services for others in the fields of pathology, immunohistochemistry, in situ-hybridization, proteomics, RNA transcription, RNA translation, gene expression profiling and nucleic acid sequencing
    3. Medical and scientific research in the field of cancer treatment and diagnosis
    4. Medical and scientific research services for others in the field of infectious disease
    5. Medical and scientific research services for others in the field of neurology
    6. Medical and scientific research services for others, namely, research and design in the field of testing, analyzing and examining biological samples, medical samples, and cell samples
    7. Providing laboratory research services for others in the field of gene expression and genetic data mining
    8. Research and development services for others for acquiring, analyzing, and managing biological and genetic information in the fields of diagnostic reagents, forensics, medicine, genetics, and environment
    9. Research, design, and development services for others in the fields of diagnostic reagents, compounds and devices, measuring apparatus for use in product research and development, separation and purification processes.